Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 46
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Effects of repeated treatment with MDMA on working memory and behavioural flexibility in mice

  • Viñals Álvarez, Xavier, 1985-
  • Maldonado, Rafael, 1961-
  • Robledo, Patricia, 1958-
Repeated administration of 3,4-methylenedioxymethamphetamine (MDMA) produces dopaminergic neurotoxicity in mice. However, it is still not clear whether this exposure induces deficits in cognitive processing related to specific subsets of executive functioning. We evaluated the effects of neurotoxic and non-neurotoxic doses of MDMA (0, 3 and 30 mg/kg, twice daily for 4 days) on working memory and attentional set-shifting in mice, and changes in extracellular levels of dopamine (DA) in the striatum. Treatment with MDMA (30 mg/kg) disrupted performance of acquired operant alternation, and this impairment was still apparent 5 days after the last drug administration. Decreased alternation was not related to anhedonia because no differences were observed between groups in the saccharin preference test under similar experimental conditions. Correct responding on delayed alternation was increased 1 day after repeated treatment with MDMA (30 mg/kg), probably because of general behavioural quiescence. Notably, the high dose regimen of MDMA impaired attentional set-shifting related to an increase in total perseveration errors. Finally, basal extracellular levels of DA in the striatum were not modified in mice repeatedly treated with MDMA with respect to controls. However, an acute challenge with MDMA (10 mg/kg) failed to increase DA outflow in mice receiving the highest MDMA dose (30 mg/kg), corroborating a decrease in the functionality of DA transporters. Seven days after this treatment, the effects of MDMA on DA outflow were recovered. These results suggest that repeated neurotoxic doses of MDMA produce lasting impairments in recall of alternation behaviour and reduce cognitive flexibility in mice., This work was supported by the DG Research of the European Commission (PHECOMP: LHSM-CT-2007-037669), the Spanish ‘Instituto de Salud Carlos III’ (RD06/001/001 and PI070709), FEDER funds, and ‘Ministerio de Ciencia e Innovación’ (SAF2007-64062), the Catalan government (SGR2009-00131) and the ICREA Foundation (ICREA Academia-2008)
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

A role for hypocretin/orexin receptor-1 in cue-induced reinstatement of nicotine-seeking behavior

  • Plaza-Zabala, Ainhoa, 1982-
  • Flores de los Heros, África, 1985-
  • Martín García, Elena, 1975-
  • Saravia Santos, Rocio, 1988-
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
Hypocretin/orexin signaling is critically involved in relapse to drug-seeking behaviors. In this study, we investigated the involvement of the hypocretin system in the reinstatement of nicotine-seeking behavior induced by nicotine-associated cues. Pretreatment with the hypocretin receptor-1 antagonist SB334867, but not with the hypocretin receptor-2 antagonist TCSOX229, attenuated cue-induced reinstatement of nicotine-seeking, which was associated with an activation of hypocretin neurons of the lateral and perifornical hypothalamic areas. In addition, relapse to nicotine-seeking increased the phosphorylation levels of GluR2-Ser880, NR1-Ser890, and p38 MAPK in the nucleus accumbens (NAc), but not in the prefrontal cortex. Notably, phosphorylation levels of NR1-Ser890 and p38 MAPK, but not GluR2-Ser880, were dependent on hypocretin receptor-1 activation. The intra-accumbens infusion of the protein kinase C (PKC) inhibitor NPC-15437 reduced nicotine-seeking behavior elicited by drug-paired cues consistent with the PKC-dependent phosphorylations of GluR2-Ser880 and NR1-Ser890. SB334867 failed to modify cue-induced reinstatement of food-seeking, which did not produce any biochemical changes in the NAc. These data identify hypocretin receptor-1 and PKC signaling as potential targets for the treatment of relapse to nicotine-seeking induced by nicotine-associated cues., This work was supported by the Instituto de Salud Carlos III grants, #PI07/0559, #PI10/00316 and #RD06/001/001 (RTA-RETICS), by the Spanish Ministry of Science and Technology, Consolider-C #SAF2007-64062 and #SAF2011-29864, the Catalan Government (SGR2009-00731), and by the Catalan Institution for Research and Advanced Studies (ICREA Academia program). Ainhoa Plaza-Zabala and África Flores are recipients of a predoctoral fellowship from the Spanish Ministry of Education
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior

  • Plaza-Zabala, Ainhoa, 1982-
  • Martín García, Elena, 1975-
  • Lecea, Luis de
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
Emerging evidence suggests that the hypocretinergic system is involved in addictive behavior. In this study, we investigated the role of these hypothalamic neuropeptides in anxiety-like responses of nicotine and stress-induced reinstatement of nicotine-seeking behavior. Acute nicotine (0.8 mg/kg, s.c.) induced anxiogenic-like effects in the elevated plus-maze and activated the paraventricular nucleus of the/nhypothalamus (PVN) as revealed by c-Fos expression. Pretreatment with the hypocretin receptor 1 (Hcrtr-1) antagonist SB334867 or/npreprohypocretin gene deletion blocked both nicotine effects. In the PVN, SB334867 also prevented the activation of corticotrophin/nreleasing factor (CRF) and arginine-vasopressin (AVP) neurons, which expressed Hcrtr-1. In addition, an increase of the percentage of c-Fos-positive hypocretin cells in the perifornical and dorsomedial hypothalamic (PFA/DMH) areas was found after nicotine (0.8 mg/kg,/ns.c.) administration. Intracerebroventricular infusion of hypocretin-1 (Hcrt-1) (0.75 nmol/1 l) or footshock stress reinstated a previously/nextinguished nicotine-seeking behavior. The effects of Hcrt-1 were blocked by SB334867, but not by the CRF1 receptor antagonist/nantalarmin. Moreover, SB334867 did not block CRF-dependent footshock-induced reinstatement of nicotine-seeking while antalarmin was effective in preventing this nicotine motivational response. Therefore, the Hcrt system interacts with CRF and AVP neurons in the PVN and modulates the anxiogenic-like effects of nicotine whereas Hcrt and CRF play a different role in the reinstatement of nicotineseeking./nIndeed, Hcrt-1 reinstates nicotine-seeking through a mechanism independent of CRF activation whereas CRF mediates the reinstatement induced by stress., This work was supported by the Instituto de Salud Carlos III Grants PI070559 (FIS) and RD06/001/001 (RTA-RETICS), by the Spanish Ministry of Science and Technology (Consolider-C, SAF2007-64062), by the European Commission (IP LSHM-CT-2004-05166, GENADDICT; and STREP LHSM-CT-2007-037669, PHECOMP), by the Catalan Institution for Research and Advanced Studies (ICREA Academia program), and by Generalitat de Catalunya (2009SGR00731). L.d.L. is supported by grants from the National Institute on Drug Abuse, National Alliance for Research on Schizophrenia and Depression, and Defense Advanced Research Projects Agency.E.M.-G.was supported by a postdoctoral fellowship from the Spanish Instituto de Salud Carlos III. A.P.-Z. is a recipient of a predoctoral fellowship from the Spanish Ministry of Education. We thank R. Cabrera, M. Linares, T. Hansson, and C. Fernández-Avilés for invaluable technical assistance, and T. Sakurai and M. Yanagisawa for generously providing preprohypocretin knock-out mice
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Operant self-administration of a sigma ligand improves nociceptive and emotional manifestations of neuropathic pain

  • Bura, S. Andreea, 1978-
  • Guegan, Thomas, 1983-
  • Zamamillo Castanedo, Daniel
  • Vela Hernández, José Miguel
  • Maldonado, Rafael, 1961-
BACKGROUND: The treatment of neuropathic pain is unsatisfactory at the present moment and the sigma 1 receptor has been identified as a new potential target for neuropathic pain. The aim of this study was to use an operant self-administration model to reveal the potential interest of a new sigma 1 receptor antagonist, S1RA, in chronic pain that was developed in mice by a partial ligation of the sciatic nerve. METHODS: Once that chronic pain had reached a steady state, mice were trained to maintain an operant behaviour to self-administer S1RA. The possible abuse liability of the analgesic compound was determined by evaluating operant self-administration in sham-operated mice. The influence of S1RA on the anhedonic state related to chronic pain was also evaluated by measuring the preference for palatable drink (2% sucrose solution) using a recently validated and highly sensitive behavioural device. RESULTS: Nerve-injured mice, but not sham-operated animals, acquired the operant responding to obtain S1RA (6 mg/kg/infusion). After 10 days of S1RA self-administration, neuropathic pain was significantly reduced in nerve-injured mice. In addition, an anhedonic state was revealed in nerve-injured mice by a decreased consumption of palatable drink, which was significantly attenuated by S1RA (25 mg/kg). CONCLUSIONS: These results reveal the analgesic efficacy of the sigma antagonist, S1RA, in neuropathic pain associated with an improvement of the emotional negative state and that was devoided of reinforcing effects. The operant responses evaluated in this new mouse model can have a high predictive value to estimate the clinical benefit/risk ratio of new analgesic compounds to treat chronic pain, such as S1RA., S1RA was provided by Esteve as a gift within research projects funded by the CENIT program (CEN-20061005) from the Centro para el Desarollo Technológico Industrial from the Spanish Ministry of Science and Innovation (#SAF2007-64062), “Redes temáticas de investigación cooperativa en salud (RETICS) del Instituto de Salud Carlos III (RD06/001/001). Red de trastornos adictivos (RTA)”, the Catalan Government (SGR2009-00131), the ICREA Foundation (ICREA Academia-2008) and the DG Research of the European Commission (PHECOMP, #LSHM-CT-2007-037669)
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The hypocretin/orexin system: implications for drug reward and relapse

  • Plaza-Zabala, Ainhoa, 1982-
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
Hypocretins (also known as orexins) are hypothalamic neuropeptides involved in the regulation of sleep/wake states and feeding behavior. Recent studies have also demonstrated an important role for the hypocretin/orexin system in the addictive properties of drugs of abuse, consistent with the reciprocal innervations between hypocretin neurons and brain areas involved in reward processing. This system participates in the primary reinforcing effects of opioids, nicotine, and alcohol. Hypocretins are also involved in the neurobiological mechanisms underlying relapse to drug-seeking behavior induced by drug-related environmental stimuli and stress, as mainly described in the case of psychostimulants. Based on these preclinical studies, the use of selective ligands targeting hypocretin receptors could represent a new therapeutical strategy for the treatment of substance abuse disorders. In this review, we discuss and update the current knowledge about the participation of the hypocretin system in drug addiction and the possible neurobiological mechanisms involved in these processes regulated by hypocretin transmission., This work was supported by the Instituto de Salud Carlos III grants #PI07/0559,/n#PI10/00316, and #RD06/001/001 (RTA-RETICS), by the Spanish Ministry of Science/nand Technology (Consolider-C, #SAF2007-64062), the Catalan Government/n(SGR2009-00731), and by the Catalan Institution for Research and Advanced Studies/n(ICREA Academia program). A Plaza-Zabala is a recipient of a predoctoral fellowship/nfrom the Spanish Ministry of Education.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Overexpression of α3/α5/β4 nicotinic receptor subunits modifies impulsive-like behavior

  • Viñals Álvarez, Xavier, 1985-
  • Molas Casacuberta, Susanna, 1985-
  • Gallego, Xavier
  • Fernández Montes, Rubén D.
  • Robledo, Patricia, 1958-
  • Dierssen, Mara
  • Maldonado, Rafael, 1961-
Recent studies have revealed that sequence variants in genes encoding the α3/α5/β4 nicotinic acetylcholine receptor subunits are associated with nicotine dependence. In this study, we evaluated two specific aspects of executive functioning related to drug addiction (impulsivity and working memory) in transgenic mice over expressing α3/α5/β4 nicotinic receptor subunits. Impulsivity and working memory were evaluated in an operant delayed alternation task, where mice must inhibit responding between 2 and 8s in order to receive food reinforcement. Working memory was also evaluated in a spontaneous alternation task in an open field. Transgenic mice showed less impulsive-like behavior than wild-type controls, and this behavioral phenotype was related to the number of copies of the transgene. Thus, transgenic Line 22 (16-28 copies) showed a more pronounced phenotype than Line 30 (4-5 copies). Overexpression of these subunits in Line 22 reduced spontaneous alternation behavior suggesting deficits in working memory processing in this particular paradigm. These results reveal the involvement of α3/α5/β4 nicotinic receptor subunits in working memory and impulsivity, two behavioral traits directly related to the vulnerability to develop nicotine dependence., Funding for this study was provided by the DG Research of the European Commission (PHECOMP, no. LHSM-CT-2007-037669), the Spanish ‘Instituto de Salud Carlos III’ (RD06/001/001; PI082038/nand PI10/01708, EU/FIS PS09102673, ERARare), the Spanish ‘Ministerio de Educación y Ciencia’ (SAF2007-64062; SAF2007-60827; SAF2007-31093-E; SAF2010-16427), Fundación Ramón Areces, Reina Sofia, Marató TV3, and CIBERER, The Catalan Government (SGR2009-00131; 2009SGR-1313) and the ICREA Foundation (ICREA Academia-2008)
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The hypocretin/orexin receptor-1 as a novel target to modulate cannabinoid reward

  • Flores de los Heros, África, 1985-
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
BACKGROUND: Cannabis is the most widely used illicit drug in the world. Although there is a high prevalence of users who seek treatment for cannabis dependence, no accepted pharmacologic treatment is available to facilitate and maintain abstinence. The hypocretin/orexin system plays a critical role in drug addiction, but the potential participation of this system in the addictive properties of cannabinoids is unknown. METHODS: We investigated the effects of hypocretins in the intravenous self-administration of the synthetic cannabinoid agonist WIN55,212-2 using hypocretin receptor-1 (Hcrtr-1) and hypocretin receptor-2 antagonists and Hcrtr-1 knockout mice. Additional groups of mice were trained to obtain water to rule out operant responding impairments. Activation of hypocretin neurons was analyzed by using double-label immunofluorescence of FosB/ΔFosB with hypocretin-1. Microdialysis studies were performed to evaluate dopamine extracellular levels in the nucleus accumbens after acute Δ(9)-tetrahydrocannabinol administration.RESULTS: Systemic administration of the Hcrtr-1 antagonist SB334867 reduced intravenous self-administration of WIN55,212-2, as well as the maximum effort to obtain a WIN55,212-2 infusion, as revealed under a progressive ratio schedule. This role of Hcrtr-1 in the reinforcing and motivational properties of WIN55,212-2 was confirmed in Hcrtr-1 knockout mice. Contingent, but not noncontingent, WIN55,212-2 self-administration increased the percentage of hypocretin cells expressing FosB/ΔFosB in the lateral hypothalamus. The enhancement in dopamine extracellular levels in the nucleus accumbens induced by Δ(9)-tetrahydrocannabinol was blocked in mice lacking the Hcrtr-1. CONCLUSIONS: /nThese findings demonstrate that Hcrtr-1 modulates the reinforcing properties of cannabinoids, which could have a clear therapeutic interest., This work was supported by the Instituto de Salud Carlos III grants, #PI07/0559, #PI10/00316 and #RD06/001/001 (RTA-RETICS), by the Spanish Ministry of Science and Technology, Consolider-C #SAF2007-64062 and #SAF2011-29864, the Catalan Government (SGR2009-00731), and by the Catalan Institution for Research and Advanced Studies (ICREA Academia program). África Flores is recipient of a predoctoral fellowship from the Spanish Ministry of Education
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate

  • La Porta, Carmen, 1985-
  • Bura, S. Andreea, 1978-
  • Aracil Fernández, Auxiliadora
  • Manzanares, Jorge
  • Maldonado, Rafael, 1961-
Joint pain is a common clinical problem for which both inflammatory and degenerative joint diseases are major causes. The purpose of this study was to investigate the role of CB1 and CB2 cannabinoid receptors in the behavioral, histological, and neurochemical alterations associated with joint pain. The murine model of monosodium iodoacetate (MIA) was used to induce joint pain in knockout mice for CB1 (CB1KO) and CB2 cannabinoid receptors (CB2KO) and transgenic mice overexpressing CB2 receptors (CB2xP). In addition, we evaluated the changes induced by MIA in gene expression of CB1 and CB2 cannabinoid receptors and μ-, δ- and κ-opioid receptors in the lumbar spinal cord of these mice. Wild-type mice, as well as CB1KO, CB2KO, and CB2xP mice, developed mechanical allodynia in the ipsilateral paw after MIA intra-articular injection. CB1KO and CB2KO demonstrated similar levels of mechanical allodynia of that observed in wild-type mice in the ipsilateral paw, whereas allodynia was significantly attenuated in CB2xP. Interestingly, CB2KO displayed a contralateral mirror image of pain developing mechanical allodynia also in the contralateral paw. All mouse lines developed similar histological changes after MIA intra-articular injection. Nevertheless, MIA intra-articular injection produced specific changes in the expression of cannabinoid and opioid receptor genes in lumbar spinal cord sections that were further modulated by the genetic alteration of the cannabinoid receptor system. These results revealed that CB2 receptor plays a predominant role in the control of joint pain manifestations and is involved in the adaptive changes induced in the opioid system under this pain state., This work was supported by the Spanish “Ministerio de Ciencia e Innovación” (#SAF2007-64062), “Instituto de Salud Carlos III” (RETICS- Red de Trastornos Adictivos-Redes Temáticas de Investigación Cooperativa en Salud: #RD06/0001/0001, #RD06/0001/1004), Plan Nacional sobre Drogas (PNSD #2009/026), the Catalan Government (SGR2009-00131), the ICREA Foundation (ICREA Academia-2008), the DG Research of the European Commission (GENADDICT, # LSHM-CT-2004-05166, and PHECOMP, # LSHM-CT-2007-037669), CENIT program (CEN-20061005) from/nthe “Centro para el Desarollo Technológico Industrial” from the Spanish Ministry of Science and Innovation. Carmen La Porta (C.L.P) is a recipient of a predoctoral fellowship from the Spanish Ministry of Education. Auxiliadora Aracil-Fernández (A.A.F., predoctoral fellow) and Analía Rico (A.R., technician) are supported by RETICS. The partial support of FEDER funds (EU) is also acknowledged
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Selective re-expression of β2 nicotinic acetylcholine receptor subunits in the ventral tegmental area of the mouse restores intravenous nicotine self-administration

  • Orejarena Serrano, María-Juliana, 1980-
  • Herrera Solís, Andrea
  • Pons, Stéphanie
  • Maskos, Uwe
  • Maldonado, Rafael, 1961-
  • Robledo, Patricia, 1958-
Beta-2 (β2) nicotinic acetylcholine receptor subunits have been particularly related with nicotine reinforcement. However, the importance of these subunits in the chronic aspects of nicotine addiction has not been established. In this study we evaluated the role of ventral tegmental area (VTA) β2 receptor subunits in the acquisition and maintenance of nicotine self-administration. We used an operant mouse model of intravenous self-administration of different doses of nicotine (15, 30, and 60 μg/kg/infusion) during 10 days in constitutive knockout mice lacking β2 receptor subunits (β2KO), wild-type (WT) controls, mice with β2 receptor subunits re-expressed in the VTA using a lentiviral vector (β2-VEC), and control knockout mice with a sham injection (KO-GFP). The results showed that β2KO mice did not reliably acquire nicotine self-administration at any of the doses tested, while WT controls showed dose-dependent acquisition of this behaviour. β2-VEC mice readily acquired and maintained nicotine self-administration at the effective dose of 15 μg/kg/infusion, while sham KO-GFP mice did not. The recovery of the WT phenotype by the re-expression of β2 receptor subunits within the VTA supports the role of this specific population in nicotine reinforcement, and reveals that they are sufficient for the acquisition and maintenance of systemic nicotine self-administration., This work was supported by the Spanish “Instituto de Salud Carlos III” (RD06/001/001 and PI10/01708), FEDER funds, and Ministerio de Ciencia e Innovación (SAF2007-64062), the Catalan Government (SGR2009-00131), an FP7 ERANET programme (NICO-GENE), the ICREA Foundation (ICREA Academia-2008), and a post-doctoral fellowship from CONACyT to AHS
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Active and passive MDMA ('ecstasy') intake induces differential transcriptional changes in the mouse brain

  • Fernández Castillo, Noelia
  • Orejarena Serrano, María-Juliana, 1980-
  • Ribasés, Marta
  • Casas, Miguel
  • Robledo, Patricia, 1958-
  • Maldonado, Rafael, 1961-
  • Cormand, Bru
3,4-Methylenedioxymethamphetamine (MDMA, 'ecstasy') is a recreational drug widely used by adolescents and young adults. Although its rewarding effects are well established, there is controversy on its addictive potential. We aimed to compare the consequences of active and passive MDMA administration on gene expression in the mouse brain since all previous studies were based on passive MDMA administration. We used a yoked-control operant intravenous self-administration paradigm combined with microarray technology. Transcriptomic profiles of ventral striatum, frontal cortex, dorsal raphe nucleus and hippocampus were analysed in mice divided in contingent MDMA, yoked MDMA and yoked saline groups, and several changes were validated by quantitative reverse transcription polymerase chain reaction (qRT-PCR). The comparison of contingent MDMA and yoked MDMA vs. yoked saline mice allowed the identification of differential expression in several genes, most of them with immunological and inflammatory functions, but others being involved in neuroadaptation. In the comparison of contingent MDMA vs. yoked MDMA administration, hippocampus and the dorsal raphe nucleus showed statistically significant changes. The altered expression of several genes involved in neuroadaptative changes and synapse function, which may be related to learning self-administration behaviour, could be validated in these two brain structures. In conclusion, our study shows a strong effect of MDMA administration on the expression of immunological and inflammatory genes in all the four brain regions studied. In addition, experiments on MDMA self-administration suggest that the dorsal raphe nucleus and hippocampus may be involved in active MDMA-seeking behaviour, and show specific alterations on gene expression that support the addictive potential of this drug., This work was supported by the Spanish ‘Ministerio de Ciencia e Innovación (MICINN)’(SAF2007-64062), ‘Instituto de Salud Carlos III’ (RD06/001/001 and PI070709), the Catalan Government (SGR2009-00131 and SGR2009-00971), the ICREA Foundation (ICREA Academia-2008), ‘Plan Nacional Sobre Drogas’ (PNSD#2009/022 and PNSD#2009/026), Fundació ‘La Marató/nde TV3’ (2007) and the DG Research of the European Commission (GENADDICT, LSHM-CT-2004-05166; and PHECOMP, LSHM-CT-2007-037669). Partial support from FEDER funds is/nalso acknowledged. MR is a recipient of a Miguel de Servet contract from ‘Instituto de Salud Carlos III-MICINN’ (Spain) and NF-C was supported by a fellowship from the Biomedical Network/nResearch Centre on Rare Diseases (CIBERER)
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Intrathecal injection of P/Q type voltage-gated calcium channel antibodies from paraneoplastic cerebellar degeneration cause ataxia in mice

  • Martín García, Elena, 1975-
  • Mannara, Francesco
  • Gutiérrez Cuesta, Javier
  • Sabater, Lidia
  • Dalmau, Josep
  • Maldonado, Rafael, 1961-
  • Graus, Francesc
The role of antibodies against the P/Q type voltage-gated calcium channels (VGCC-ab) in the pathogenesis of paraneoplastic cerebellar degeneration (PCD) and lung cancer is unclear. We evaluated in mice the effect of intrathecal injection of IgG purified from serum of a patient with both PCD and Lambert-Eaton myasthenic syndrome (LEMS), and from another patient with isolated LEMS. Mice injected with PCD/LEMS IgG developed marked, reversible ataxia compared with those injected with LEMS or control IgG. These findings suggest that P/Q-type VGCC-ab may play a role in the pathogenesis of ataxia in patients with PCD and SCLC., This study was supported in part by grants PS09/0193 (FG) and PS11/01780 (JD) from Fondo de Investigaciones Sanitarias, Madrid; grant from Fundació la Marató de TV3 (JD), Barcelona; and grants from the “Ministerio de Ciencia e Innovación” (SAF2007-64062), and “Instituto de Salud Carlos III” (RETICS-Red de Trastornos Adictivos-Redes Temáticas de Investigación Cooperativa en Salud: RD06/0001/0001, RD06/0001/1004) (RM), Spain.The partial support of FEDER funds (EU) is also acknowledged
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Endocannabinoid system and drug addiction: new insights from mutant mice approaches

  • Maldonado, Rafael, 1961-
  • Robledo, Patricia, 1958-
  • Berrendero Díaz, Fernando, 1971-
The involvement of the endocannabinoid system in drug addiction was initially studied by the use of compounds with different affinities for each cannabinoid receptor or for the proteins involved in endocannabinoids inactivation. The generation of genetically modified mice with selective mutations in these endocannabinoid system components has now provided important advances in establishing their specific contribution to drug addiction. These genetic tools have identified the particular interest of CB1 cannabinoid receptor and endogenous anandamide as potential targets for drug addiction treatment. Novel genetic tools will allow determining if the modulation of CB2 cannabinoid receptor activity and 2-arachidonoylglycerol tone can also have an important therapeutic relevance for drug addiction., This work was supported by the Spanish “Ministerio de Ciencia e Innovación” (#SAF2007-64062 and SAF2011-29864), “Instituto de Salud Carlos III” (RETICS- Red de Trastornos Adictivos-Redes Temáticas de Investigación Cooperativa en Salud: #RD06/0001/0001, #RD06/0001/1004), grants #10/00316 and #10/01708, Plan Nacional sobre Drogas (PNSD #2009/026), the Catalan Government (SGR2009-00131) and the ICREA Foundation (ICREA Academia-2008)
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain

  • Racz, Ildiko
  • Nadal i Roura, Xavier, 1980-
  • Alferink, Judith
  • Baños i Díez, Josep Eladi
  • Rehnelt, Jennifer
  • Martín Sánchez, Miquel, 1971-
  • Pintado, Belén
  • Gutierrez-Adan, Alfonso
  • Sanguino, Elena
  • Manzanares, Jorge
  • Zimmer, Andreas
  • Maldonado, Rafael, 1961-
Neuropathic pain is a clinical manifestation of nerve injury difficult to treat even with potent analgesic compounds. Here, we used different lines of genetically modified mice to clarify the role played by CB2 cannabinoid receptors in the regulation of the central immune responses leading to the development of neuropathic pain. CB2 knock-out mice and wild-type littermates were exposed to sciatic nerve injury, and both genotypes developed a similar hyperalgesia and allodynia in the ipsilateral paw. Most strikingly, knock-outs also developed a contralateral mirror image pain, associated with an enhanced microglial and astrocytic expression in the contralateral spinal horn. In agreement, hyperalgesia, allodynia, and microglial and astrocytic activation induced by sciatic nerve injury were attenuated in transgenic mice overexpressing CB2 receptors. These results demonstrate the crucial role of CB2 cannabinoid receptor in modulating glial activation in response to nerve injury. The enhanced manifestations of neuropathic pain were replicated in irradiated wild-type mice reconstituted with bone marrow cells from CB2 knock-outs, thus demonstrating the implication of the CB2 receptor expressed in hematopoietic cells in the development of neuropathic pain at the spinal cord., This work was supported by grants from the National Institute on Drug Abuse (1R01-DA016768-0111) (R.M.,A.Z.), European Commission [Framework VI, GENADDICT OJ 2004/C164, 005166 (R.M., A.Z.); PHECOM, LSHM-CT-2007-037669 (R.M.)], Ministerio de Educación y Ciencia (BFU2004-00920/BFI; SAF2007-64062) (R.M.), Generalitat de Catalunya (R.M.), Deutsche Forschungsgemeinschaft (SFB645; FOR926) (A.Z.), and Bundesministerium für Bildung und Forschung (NGFN2) (A.Z.).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Influence of δ-opioid receptors in the behavioral effects of nicotine

  • Berrendero Díaz, Fernando, 1971-
  • Plaza-Zabala, Ainhoa, 1982-
  • Galeote González, Lola
  • Flores de los Heros, África, 1985-
  • Bura, S. Andreea, 1978-
  • Kieffer, Brigitte L.
  • Maldonado, Rafael, 1961-
Multiple studies in animal models and humans suggest that the endogenous opioid system is an important neurobiological substrate for nicotine addictive properties. In this study, we evaluated the participation of δ-opioid receptors in different behavioral responses of nicotine by using δ-opioid receptor knockout mice. Acute nicotine administration induced hypolocomotion and antinociception in wild-type mice, which were similar in knockout animals. The development of tolerance to nicotine-induced antinociception was also similar in both genotypes. In agreement, the expression and functional activity of δ-opioid receptors were not modified in the different layers of the spinal cord and brain areas evaluated after chronic nicotine treatment. The somatic manifestation of the nicotine withdrawal syndrome precipitated by mecamylamine was also similar in wild-type and δ-opioid receptor knockout mice. In contrast, nicotine induced a conditioned place preference in wild-type animals that was abolished in knockout mice. Moreover, a lower percentage of acquisition of intravenous nicotine self-administration was observed in mice lacking δ-opioid receptors as well as in wild-type mice treated with the selective δ-opioid receptor antagonist naltrindole. Accordingly, in-vivo microdialysis studies revealed that the enhancement in dopamine extracellular levels induced by nicotine in the nucleus accumbens was reduced in mutant mice. In summary, the present results show that δ-opioid receptors are involved in the modulation of nicotine rewarding effects. However, this opioid receptor does not participate either in several acute effects of nicotine or in the development of tolerance and physical dependence induced by chronic nicotine administration., This work was supported by the Spanish “Ministerio de Ciencia e Innovación”/n(#SAF2007-64062 and #SAF-2011-29864), the “Instituto de Salud Carlos III” grants/n#PI07/0559, #PI10/00316 and #RD06/001/001, the “Plan Nacional Sobre Drogas”/n(#2009/026), the Catalan Government (SGR2009-00131), and the ICREA Foundation/n(ICREA Academia Award-2008) to R.M. Partial support of FEDER funds is also acknowledged.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Involvement of 5-HT2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour

  • Orejarena Serrano, María-Juliana, 1980-
  • Lanfumey, Laurence
  • Maldonado, Rafael, 1961-
  • Robledo, Patricia, 1958-
The serotonergic system appears crucial for (±)-3,4-methylenedioxymethamphetamine (MDMA) reinforcing properties. Current evidence indicates that serotonin 5-HT2A receptors (5-HT2ARs) modulate mesolimbic dopamine (DA) activity and several behavioural responses related to the addictive properties of psychostimulants. This study evaluated the role of 5-HT2ARs in MDMA-induced reinforcement and hyperlocomotion, and the reinstatement of MDMA-seeking behaviour. Basal and MDMA-stimulated extracellular levels of DA in the nucleus accumbens (NAc) and serotonin and noradrenaline in the prefrontal cortex were also assessed. Self-administration of MDMA was blunted in 5-HT2AR knockout (KO) mice compared to wild-type (WT) littermates at both doses tested (0.125 and 0.25 mg/kg per infusion). Horizontal locomotion was increased by MDMA (10 and 20 mg/kg i.p.) to a higher extent in KO than in WT mice. DA outflow in the NAc was lower in KO compared to WT mice under basal conditions and after MDMA (20 mg/kg) challenge. In WT mice, MDMA (5 and 10 mg/kg i.p.) priming did not reinstate MDMA-seeking behaviour, while cue-induced reinstatement was prominent. This cue-induced reinstatement was blocked by administration of the selective 5-HT2AR antagonist, SR46349B (eplivanserin) at a dose of 0.5 mg/kg, but not at 0.25 mg/kg. Our results indicate that 5-HT2ARs are crucial for MDMA-induced reinforcement and cue-induced reinstatement of MDMA-seeking behaviour. These effects are probably due to the modulation of mesolimbic dopaminergic activity., This work was supported by the Instituto de Salud Carlos III FIS grant no. PI070709 (to P.R.) and Red de trastornos adictivos (RTA-RETICS) grant no. RD06/001/001 (to R.M.), the Ministerio de Ciencia e Innovación grant no. SAF2007-64062 (to R.M.), the Generalitat de Catalunya grant no. 2009SGR00731 and ICREA Academia award (to R.M.) and the European Commission projects GENADDICT (no. LSHM-CT-2004-05166) and PHECOMP (no. LSHM-CT-037669) (both to R.M.)
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Nicotine anxiogenic and rewarding effects are decreased in mice lacking β-endorphin

  • Trigo i Rodríguez, Josep M.
  • Zimmer, Andreas
  • Maldonado, Rafael, 1961-
The endogenous opioid system plays an important role in the behavioral effects of nicotine. Thus, micro-opioid receptor and the endogenous opioids derived from proenkephalin are involved in the central effects of nicotine. However, the role played by the different endogenous opioid peptides in the acute and chronic effects of nicotine remains to be fully established. Mice lacking beta-endorphin were acutely injected with nicotine at different doses to evaluate locomotor, anxiogenic and antinociceptive responses. The rewarding properties of nicotine were evaluated by using the conditioned place-preference paradigm. Mice chronically treated with nicotine were acutely injected with mecamylamine to study the behavioral expression of nicotine withdrawal. Mice lacking beta-endorphin exhibited a spontaneous hypoalgesia and hyperlocomotion and a reduction on the anxiogenic and rewarding effects induced by nicotine. Nicotine induced similar antinociception and hypolocomotion in both genotypes and no differences were found in the development of physical dependence. The dissociation between nicotine rewarding properties and physical dependence suggests a differential implication of beta-endorphin in these addictive related responses., This work was supported by NIDA (1R01-DA01 6768-0111), Ministerio de Ciencia y Tecnología (SAF2007-64062), Instituto de Salud Carlos III Red de Trastornos Adictivos, Generalitat de Catalunya (2005SGR00131 and ICREA Academia). European Commission (GENADDICT OJ 2004/C164, N005166 and PHECOMP LSHM-CT-2007-037669).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Operant behavior to obtain palatable food modifies neuronal plasticity in the brain reward circuit

  • Guegan, Thomas, 1983-
  • Cutando Ruiz, Laura, 1985-
  • Ayuso, Eduard
  • Santini, Emanuela
  • Fisone, Gilberto
  • Bosch, Fatima
  • Martínez, Albert
  • Valjent, Emmanuel
  • Maldonado, Rafael, 1961-
  • Martín Sánchez, Miquel, 1971-
Palatability enhances food intake by hedonic mechanisms that prevail over caloric necessities. Different studies have demonstrated the role of endogenous cannabinoids in the mesocorticolimbic system in controlling food hedonic value and consumption. We hypothesize that the endogenous cannabinoid system could also be involved in the development of food-induced behavioral alterations, such as food-seeking and binge-eating, by a mechanism that requires neuroplastic changes in the brain reward pathway. For this purpose, we evaluated the role of the CB1 cannabinoid receptor (CB1-R) in the behavioral and neuroplastic changes induced by operant training for standard, highly caloric or highly palatable isocaloric food using different genetics, viral and pharmacological approaches. Neuroplasticity was evaluated by measuring changes in dendritic spine density in neurons previously labeled with the dye DiI. Only operant training to obtain highly palatable isocaloric food induced neuroplastic changes in neurons of the nucleus accumbens shell and prefrontal cortex that were associated to changes in food-seeking behavior. These behavioral and neuroplastic modifications induced by highly palatable isocaloric food were dependent on the activity of the CB1-R. Neuroplastic changes induced by highly palatable isocaloric food are similar to those produced by some drugs of abuse and may be crucial in the alteration of food-seeking behavior leading to overweight and obesity., This work was supported by the Spanish Ministerio de Ciencia e Innovació (#SAF2007-64062 and #SAF2008-00962), the Instituto de Salud CarlosIII (#RD06/001/001), the Plan Nacional sobre Drogas, the Catalan Government (SGR2009-00131 and SGR2009-224), the ICREA Foundation (ICREA Academia-2008), the DG Research of the European Commission (GENADDICT,/n#LSHM-CT-2004-05166; and PHECOMP, #LSHM-CT-2007-037669) the FIS’’ (PI07/0715),ATIP-Avenir and Sanofi-Aventis grants.This work was also supported by the Plan Nacional Sobre Drogas (#2009/026) to R.M.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure

  • Cutando Ruiz, Laura, 1985-
  • Busquets Garcia, Arnau, 1985-
  • Puighermanal Puigvert, Emma, 1983-
  • Gomis González, Maria, 1988-
  • Delgado García, José María
  • Gruart, Agnès
  • Maldonado, Rafael, 1961-
  • Ozaita Mintegui, Andrés, 1969-
Chronic cannabis exposure can lead to cerebellar dysfunction in humans, but the neurobiological mechanisms involved remain incompletely understood. Here, we found that in mice, subchronic administration of the psychoactive component of cannabis, delta9-tetrahydrocannabinol (THC), activated cerebellar microglia and increased the expression of neuroinflammatory markers, including IL-1β. This neuroinflammatory phenotype correlated with deficits in cerebellar conditioned learning and fine motor coordination. The neuroinflammatory phenotype was readily detectable in the cerebellum of mice with global loss of the CB1 cannabinoid receptor (CB1R, Cb1(-/-) mice) and in mice lacking CB1R in the cerebellar parallel fibers, suggesting that CB1R downregulation in the cerebellar molecular layer plays a key role in THC-induced cerebellar deficits. Expression of CB2 cannabinoid receptor (CB2R) and Il1b mRNA was increased under neuroinflammatory conditions in activated CD11b-positive microglial cells. Furthermore, administration of the immunosuppressant minocycline or an inhibitor of IL-1β receptor signaling prevented the deficits in cerebellar function in Cb1(-/-) and THC-withdrawn mice. Our results suggest that cerebellar microglial activation plays a crucial role in the cerebellar deficits induced by repeated cannabis exposure., This study was supported by grants from the Ministerio de Ciencia e Innovación (BFU2008-03390, to A. Gruart; BFU2008-00899, to J.M. Delgado-García; SAF2007-64062 and SAF2011-29864, to R. Maldonado; and SAF2009-07309 and BFU2012-33500, to A. Ozaita); the European Commission (PHECOMP, LSHM-CT-2007-037669, to R. Maldonado); the Instituto de Salud Carlos III (RTA-RETICS, RD06/001/001, to R. Maldonado); the Generalitat de Catalunya (SGR2009-SGR00731, to R. Maldonado); the Fundació La Marató de TV3 (090910, to A. Ozaita); and the ICREA Academia (to R. Maldonado). Partial support from the EU FEDER funds is also acknowledged.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Hypocretin/orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawal

  • Plaza-Zabala, Ainhoa, 1982-
  • Flores de los Heros, África, 1985-
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
BACKGROUND: Hypocretin (orexin) signaling is involved in drug addiction. In this study, we investigated the role of these hypothalamic neuropeptides in nicotine withdrawal by using behavioral and neuroanatomical approaches. METHODS: Nicotine withdrawal syndrome was precipitated by mecamylamine (2 mg/kg, subcutaneous) in C57BL/6J nicotine-dependent mice (25 mg/kg/day for 14 days) pretreated with the hypocretin receptor 1 (Hcrtr-1) antagonist SB334867 (5 and 10 mg/kg, intraperitoneal), the hypocretin receptor 2 antagonist TCSOX229 (5 and 10 mg/kg, intraperitoneal), and in preprohypocretin knockout mice. c-Fos expression was analyzed in several brain areas related to nicotine dependence by immunofluorescence techniques. Retrograde tracing with rhodamine-labeled fluorescent latex microspheres was used to determine whether the hypocretin neurons project directly to the paraventricular nucleus of the hypothalamus (PVN), and SB334867 was locally administered intra-PVN (10 nmol/side) to test the specific involvement of Hcrtr-1 in this brain area during nicotine withdrawal./nRESULTS: Somatic signs of nicotine withdrawal were attenuated in mice pretreated with SB334867 and in preprohypocretin knockout mice. No changes were found in TCSOX229 pretreated animals. Nicotine withdrawal increased the percentage of hypocretin cells expressing c-Fos in the perifornical, dorsomedial, and lateral hypothalamus. In addition, the increased c-Fos expression in the PVN during withdrawal was dependent on hypocretin transmission through Hcrtr-1 activation. Hypocretin neurons directly innervate the PVN and the local infusion of SB334867 into the PVN decreased the expression of nicotine withdrawal. CONCLUSIONS: These data demonstrate that hypocretin signaling acting on Hcrtr-1 in the PVN plays a crucial role in the expression of nicotine withdrawal., This work was supported by the Instituto de Salud Carlos III grants #PI07/0559,/n#PI10/00316, and #RD06/001/001 (RTA-RETICS), by the Spanish Ministry of Science/nand Technology (Consolider-C, #SAF2007-64062), the Catalan Government/n(SGR2009-00731), and by the Catalan Institution for Research and Advanced Studies/n(ICREA Academia program). A Plaza-Zabala is a recipient of a predoctoral fellowship/nfrom the Spanish Ministry of Education
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Operant model of frustrated expected reward in mice

  • Burokas, Aurelijus, 1982-
  • Gutiérrez Cuesta, Javier
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
One aspect of the addictive process that has not been thoroughly investigated is the consequence of the frustrated state occurring when the drug is not available. The present study aimed to validate a novel operant model of frustrated expected reward in mice. C57BL/6J mice were trained in operant conditioning maintained by chocolate-flavoured pellets or cocaine. After the completion of high rates of responding on a progressive ratio schedule, the reward was unexpectedly withheld. The consequences of this frustrated behaviour on anxiety, aggressiveness, perseveration, extinction and reinstatement were investigated. Mice exposed to the frustrated event perseverated in the operant responses and showed increased aggressiveness in the resident-intruder test. These animals also showed higher rates of cue-induced reinstatement of drug seeking. The present study provides a reliable operant model in mice to evaluate a frustrated state following reward unavailability. This animal model could be useful to study the behavioural and neurochemical consequences related to the emotional states generated during the omission of a highly expected reward., This work was supported by the DG Research of the European Commission (PHECOMP, no. LHSM-CT-2007—037669 and GENADDICT, no. LSHM-CT-2004—05166), the Spanish ‘Instituto de Salud Carlos III’ (RTA, no. RD06/001/001), the Spanish ‘Ministerio de Ciencia e Innovación’ (no. SAF2007-64062), the Spanish ‘Ministerio de Sanidad, Política Social e Igualdad’ (Plan/nNacional Sobre Drogas, no. 2009/026), the Catalan Government (SGR2009-00131), the ICREA Foundation (ICREA Academia-2008). A.B. was supported by an FI pre-doctoral fellowship of the Catalan Government; J.G.-C. was supported by a ‘Juan de la Cierva’ postdoctoral fellowship from the Spanish ‘Ministerio de Ciencia e Innovación’; and E.M.-G. was supported by a ‘Sara Borrell’ post-doctoral fellowship from the Spanish ‘Instituto de Salud Carlos III’. Partial support from FEDER funds is also acknowledged
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far

  • Flores de los Heros, África, 1985-
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
Emerging findings suggest the existence of a cross-talk between hypocretinergic and endocannabinoid systems. Although few studies have examined this relationship, the apparent overlap observed in the neuroanatomical distribution of both systems as well as their putative functions strongly point to the existence of such cross-modulation. In agreement, biochemical and functional studies have revealed the existence of heterodimers between CB1 cannabinoid receptor and hypocretin receptor-1, which modulates the cellular localization and downstream signaling of both receptors. Moreover, the activation of hypocretin receptor-1 stimulates the synthesis of 2-arachidonoyl glycerol culminating in the retrograde inhibition of neighboring cells and suggesting that endocannabinoids could contribute to some hypocretin effects. Pharmacological data indicate that endocannabinoids and hypocretins might have common physiological functions in the regulation of appetite, reward and analgesia. In contrast, these neuromodulatory systems seem to play antagonistic roles in the regulation of sleep/wake cycle and anxiety-like responses. The present review attempts to piece together what is known about this interesting interaction and describes its potential therapeutic implications., This work was supported by the Instituto de Salud CarlosIII grants, #PI07/0559, #PI10/00316 and #RD06/001/001 (RTA-RETICS), by the Spanish Ministry of Science and Technology, Consolider-C #SAF2007-64062 and #SAF2011-29864, the Catalan Government (SGR2009-00731), and by the Catalan Institution for Research and Advanced Studies (ICREA Academia program). África Flores is recipient of a predoctoral fellowship from the Spanish Ministry of Education
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain

  • Racz, Ildiko
  • Nadal i Roura, Xavier, 1980-
  • Alferink, Judith
  • Baños i Díez, Josep Eladi
  • Rehnelt, Jennifer
  • Martín, Miguel
  • Pintado, Belén
  • Gutierrez-Adan, Alfonso
  • Sanguino, Elena
  • Bellora Pereyra, Nicolás
  • Manzanares, Jorge
  • Zimmer, Andreas
  • Maldonado, Rafael, 1961-
Nerve injuries often lead to neuropathic pain syndrome. The mechanisms contributing to this syndrome involve local inflammatory responses, activation of glia cells, and changes in the plasticity of neuronal nociceptive pathways. Cannabinoid CB(2) receptors contribute to the local containment of neuropathic pain by modulating glial activation in response to nerve injury. Thus, neuropathic pain spreads in mice lacking CB(2) receptors beyond the site of nerve injury. To further investigate the mechanisms leading to the enhanced manifestation of neuropathic pain, we have established expression profiles of spinal cord tissues from wild-type and CB(2)-deficient mice after nerve injury. An enhanced interferon-gamma (IFN-gamma) response was revealed in the absence of CB(2) signaling. Immunofluorescence stainings demonstrated an IFN-gamma production by astrocytes and neurons ispilateral to the nerve injury in wild-type animals. In contrast, CB(2)-deficient mice showed neuronal and astrocytic IFN-gamma immunoreactivity also in the contralateral region, thus matching the pattern of nociceptive hypersensitivity in these animals. Experiments in BV-2 microglia cells revealed that transcriptional changes induced by IFN-gamma in two key elements for neuropathic pain development, iNOS (inducible nitric oxide synthase) and CCR2, are modulated by CB(2) receptor signaling. The most direct support for a functional involvement of IFN-gamma as a mediator of CB(2) signaling was obtained with a double knock-out mouse strain deficient in CB(2) receptors and IFN-gamma. These animals no longer show the enhanced manifestations of neuropathic pain observed in CB(2) knock-outs. These data clearly demonstrate that the CB(2) receptor-mediated control of neuropathic pain is IFN-gamma dependent., This work was supported by grants from the National Institute on Drug Abuse (1R01-DA016768-0111) (R.M.,A.Z.), European Commission [Framework VI, GENADDICT OJ 2004/C164, 005166 (R.M., A.Z.); PHECOM, LSHM-CT-2007-037669 (R.M.)], Ministerio de Educación y Ciencia (BFU2004-00920/BFI; SAF2007-64062) (R.M.), Generalitat de Catalunya (R.M.), Deutsche Forschungsgemeinschaft (SFB645; FOR926) (A.Z.), and Bundesministerium für Bildung und Forschung (NGFN2) (A.Z.)
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system

  • Berrendero Díaz, Fernando, 1971-
  • Robledo, Patricia, 1958-
  • Trigo i Rodríguez, Josep M.
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
Nicotine is the primary component of tobacco that maintains the smoking habit and develops addiction. The adaptive changes of nicotinic acetylcholine receptors produced by repeated exposure to nicotine play a crucial role in the establishment of dependence. However, other neurochemical systems also participate in the addictive effects of nicotine including glutamate, cannabinoids, GABA and opioids. This review will cover the involvement of these neurotransmitters in nicotine addictive properties, with a special emphasis on the endogenous opioid system. Thus, endogenous enkephalins and beta-endorphins acting on mu-opioid receptors are involved in nicotine-rewarding effects, whereas opioid peptides derived from prodynorphin participate in nicotine aversive responses. An up-regulation of mu-opioid receptors has been reported after chronic nicotine treatment that could counteract the development of nicotine tolerance, whereas the down-regulation induced on kappa-opioid receptors seems to facilitate nicotine tolerance. Endogenous enkephalins acting on mu-opioid receptors also play a role in the development of physical dependence to nicotine. In agreement with these actions of the endogenous opioid system, the opioid antagonist naltrexone has shown to be effective for smoking cessation in certain sub-populations of smokers., This work was supported by the Spanish “Ministerio de Ciencia e Innovación” (#SAF2007-64062) and “Instituto de Salud Carlos III” (#RD06/001/001, PI070709 and PI070559), the Catalan Government (SGR2009-00131), the ICREA Foundation (ICREA Academia-2008), NIDA (1R01-DA01 6768-0111) and the DG Research of the European Commission (NEWMOOD LSHM-CT-2004-503474; GENADDICT, #LSHM-CT-2004-05166; and PHECOMP, #LSHM-CT-2007-037669). J.M.T and E.M.G. are post-doctoral fellows of Instituto de Salud Carlos III “Contratos posdoctorales de perfeccionamiento Sara Borrell”.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Intrathecal injection of P/Q type voltage-gated calcium channel antibodies from paraneoplastic cerebellar degeneration cause ataxia in mice

  • Martín García, Elena, 1975-
  • Mannara, Francesco
  • Gutiérrez Cuesta, Javier
  • Sabater, Lidia
  • Dalmau, Josep
  • Maldonado, Rafael, 1961-
  • Graus, Francesc
The role of antibodies against the P/Q type voltage-gated calcium channels (VGCC-ab) in the pathogenesis of paraneoplastic cerebellar degeneration (PCD) and lung cancer is unclear. We evaluated in mice the effect of intrathecal injection of IgG purified from serum of a patient with both PCD and Lambert-Eaton myasthenic syndrome (LEMS), and from another patient with isolated LEMS. Mice injected with PCD/LEMS IgG developed marked, reversible ataxia compared with those injected with LEMS or control IgG. These findings suggest that P/Q-type VGCC-ab may play a role in the pathogenesis of ataxia in patients with PCD and SCLC., This study was supported in part by grants PS09/0193 (FG) and PS11/01780 (JD) from Fondo de Investigaciones Sanitarias, Madrid; grant from Fundació la Marató de TV3 (JD), Barcelona; and grants from the “Ministerio de Ciencia e Innovación” (SAF2007-64062), and “Instituto de Salud Carlos III” (RETICS-Red de Trastornos Adictivos-Redes Temáticas de Investigación Cooperativa en Salud: RD06/0001/0001, RD06/0001/1004) (RM), Spain.The partial support of FEDER funds (EU) is also acknowledged
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain

  • Racz, Ildiko
  • Nadal i Roura, Xavier, 1980-
  • Alferink, Judith
  • Baños i Díez, Josep Eladi
  • Rehnelt, Jennifer
  • Rodríguez Codina, Martín Miguel
  • Pintado, Belén
  • Gutierrez-Adan, Alfonso
  • Sanguino, Elena
  • Bellora Pereyra, Nicolás
  • Manzanares, Jorge
  • Zimmer, Andreas
  • Maldonado, Rafael, 1961-
Nerve injuries often lead to neuropathic pain syndrome. The mechanisms contributing to this syndrome involve local inflammatory responses, activation of glia cells, and changes in the plasticity of neuronal nociceptive pathways. Cannabinoid CB(2) receptors contribute to the local containment of neuropathic pain by modulating glial activation in response to nerve injury. Thus, neuropathic pain spreads in mice lacking CB(2) receptors beyond the site of nerve injury. To further investigate the mechanisms leading to the enhanced manifestation of neuropathic pain, we have established expression profiles of spinal cord tissues from wild-type and CB(2)-deficient mice after nerve injury. An enhanced interferon-gamma (IFN-gamma) response was revealed in the absence of CB(2) signaling. Immunofluorescence stainings demonstrated an IFN-gamma production by astrocytes and neurons ispilateral to the nerve injury in wild-type animals. In contrast, CB(2)-deficient mice showed neuronal and astrocytic IFN-gamma immunoreactivity also in the contralateral region, thus matching the pattern of nociceptive hypersensitivity in these animals. Experiments in BV-2 microglia cells revealed that transcriptional changes induced by IFN-gamma in two key elements for neuropathic pain development, iNOS (inducible nitric oxide synthase) and CCR2, are modulated by CB(2) receptor signaling. The most direct support for a functional involvement of IFN-gamma as a mediator of CB(2) signaling was obtained with a double knock-out mouse strain deficient in CB(2) receptors and IFN-gamma. These animals no longer show the enhanced manifestations of neuropathic pain observed in CB(2) knock-outs. These data clearly demonstrate that the CB(2) receptor-mediated control of neuropathic pain is IFN-gamma dependent., This work was supported by grants from the National Institute on Drug Abuse (1R01-DA016768-0111) (R.M.,A.Z.), European Commission [Framework VI, GENADDICT OJ 2004/C164, 005166 (R.M., A.Z.); PHECOM, LSHM-CT-2007-037669 (R.M.)], Ministerio de Educación y Ciencia (BFU2004-00920/BFI; SAF2007-64062) (R.M.), Generalitat de Catalunya (R.M.), Deutsche Forschungsgemeinschaft (SFB645; FOR926) (A.Z.), and Bundesministerium für Bildung und Forschung (NGFN2) (A.Z.)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure

  • Cutando Ruiz, Laura, 1985-
  • Busquets Garcia, Arnau, 1985-
  • Puighermanal Puigvert, Emma, 1983-
  • Gomis González, Maria, 1988-
  • Delgado García, José María
  • Gruart, Agnès
  • Maldonado, Rafael, 1961-
  • Ozaita Mintegui, Andrés, 1969-
Chronic cannabis exposure can lead to cerebellar dysfunction in humans, but the neurobiological mechanisms involved remain incompletely understood. Here, we found that in mice, subchronic administration of the psychoactive component of cannabis, delta9-tetrahydrocannabinol (THC), activated cerebellar microglia and increased the expression of neuroinflammatory markers, including IL-1β. This neuroinflammatory phenotype correlated with deficits in cerebellar conditioned learning and fine motor coordination. The neuroinflammatory phenotype was readily detectable in the cerebellum of mice with global loss of the CB1 cannabinoid receptor (CB1R, Cb1(-/-) mice) and in mice lacking CB1R in the cerebellar parallel fibers, suggesting that CB1R downregulation in the cerebellar molecular layer plays a key role in THC-induced cerebellar deficits. Expression of CB2 cannabinoid receptor (CB2R) and Il1b mRNA was increased under neuroinflammatory conditions in activated CD11b-positive microglial cells. Furthermore, administration of the immunosuppressant minocycline or an inhibitor of IL-1β receptor signaling prevented the deficits in cerebellar function in Cb1(-/-) and THC-withdrawn mice. Our results suggest that cerebellar microglial activation plays a crucial role in the cerebellar deficits induced by repeated cannabis exposure., This study was supported by grants from the Ministerio de Ciencia e Innovación (BFU2008-03390, to A. Gruart; BFU2008-00899, to J.M. Delgado-García; SAF2007-64062 and SAF2011-29864, to R. Maldonado; and SAF2009-07309 and BFU2012-33500, to A. Ozaita); the European Commission (PHECOMP, LSHM-CT-2007-037669, to R. Maldonado); the Instituto de Salud Carlos III (RTA-RETICS, RD06/001/001, to R. Maldonado); the Generalitat de Catalunya (SGR2009-SGR00731, to R. Maldonado); the Fundació La Marató de TV3 (090910, to A. Ozaita); and the ICREA Academia (to R. Maldonado). Partial support from the EU FEDER funds is also acknowledged.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Effects of repeated treatment with MDMA on working memory and behavioural flexibility in mice

  • Viñals Álvarez, Xavier, 1985-
  • Maldonado, Rafael, 1961-
  • Robledo, Patricia, 1958-
Repeated administration of 3,4-methylenedioxymethamphetamine (MDMA) produces dopaminergic neurotoxicity in mice. However, it is still not clear whether this exposure induces deficits in cognitive processing related to specific subsets of executive functioning. We evaluated the effects of neurotoxic and non-neurotoxic doses of MDMA (0, 3 and 30 mg/kg, twice daily for 4 days) on working memory and attentional set-shifting in mice, and changes in extracellular levels of dopamine (DA) in the striatum. Treatment with MDMA (30 mg/kg) disrupted performance of acquired operant alternation, and this impairment was still apparent 5 days after the last drug administration. Decreased alternation was not related to anhedonia because no differences were observed between groups in the saccharin preference test under similar experimental conditions. Correct responding on delayed alternation was increased 1 day after repeated treatment with MDMA (30 mg/kg), probably because of general behavioural quiescence. Notably, the high dose regimen of MDMA impaired attentional set-shifting related to an increase in total perseveration errors. Finally, basal extracellular levels of DA in the striatum were not modified in mice repeatedly treated with MDMA with respect to controls. However, an acute challenge with MDMA (10 mg/kg) failed to increase DA outflow in mice receiving the highest MDMA dose (30 mg/kg), corroborating a decrease in the functionality of DA transporters. Seven days after this treatment, the effects of MDMA on DA outflow were recovered. These results suggest that repeated neurotoxic doses of MDMA produce lasting impairments in recall of alternation behaviour and reduce cognitive flexibility in mice., This work was supported by the DG Research of the European Commission (PHECOMP: LHSM-CT-2007-037669), the Spanish ‘Instituto de Salud Carlos III’ (RD06/001/001 and PI070709), FEDER funds, and ‘Ministerio de Ciencia e Innovación’ (SAF2007-64062), the Catalan government (SGR2009-00131) and the ICREA Foundation (ICREA Academia-2008)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Active and passive MDMA ('ecstasy') intake induces differential transcriptional changes in the mouse brain

  • Fernández Castillo, Noelia
  • Orejarena Serrano, María-Juliana, 1980-
  • Ribasés, Marta
  • Casas, Miguel
  • Robledo, Patricia, 1958-
  • Maldonado, Rafael, 1961-
  • Cormand, Bru
3,4-Methylenedioxymethamphetamine (MDMA, 'ecstasy') is a recreational drug widely used by adolescents and young adults. Although its rewarding effects are well established, there is controversy on its addictive potential. We aimed to compare the consequences of active and passive MDMA administration on gene expression in the mouse brain since all previous studies were based on passive MDMA administration. We used a yoked-control operant intravenous self-administration paradigm combined with microarray technology. Transcriptomic profiles of ventral striatum, frontal cortex, dorsal raphe nucleus and hippocampus were analysed in mice divided in contingent MDMA, yoked MDMA and yoked saline groups, and several changes were validated by quantitative reverse transcription polymerase chain reaction (qRT-PCR). The comparison of contingent MDMA and yoked MDMA vs. yoked saline mice allowed the identification of differential expression in several genes, most of them with immunological and inflammatory functions, but others being involved in neuroadaptation. In the comparison of contingent MDMA vs. yoked MDMA administration, hippocampus and the dorsal raphe nucleus showed statistically significant changes. The altered expression of several genes involved in neuroadaptative changes and synapse function, which may be related to learning self-administration behaviour, could be validated in these two brain structures. In conclusion, our study shows a strong effect of MDMA administration on the expression of immunological and inflammatory genes in all the four brain regions studied. In addition, experiments on MDMA self-administration suggest that the dorsal raphe nucleus and hippocampus may be involved in active MDMA-seeking behaviour, and show specific alterations on gene expression that support the addictive potential of this drug., This work was supported by the Spanish ‘Ministerio de Ciencia e Innovación (MICINN)’(SAF2007-64062), ‘Instituto de Salud Carlos III’ (RD06/001/001 and PI070709), the Catalan Government (SGR2009-00131 and SGR2009-00971), the ICREA Foundation (ICREA Academia-2008), ‘Plan Nacional Sobre Drogas’ (PNSD#2009/022 and PNSD#2009/026), Fundació ‘La Marató/nde TV3’ (2007) and the DG Research of the European Commission (GENADDICT, LSHM-CT-2004-05166; and PHECOMP, LSHM-CT-2007-037669). Partial support from FEDER funds is/nalso acknowledged. MR is a recipient of a Miguel de Servet contract from ‘Instituto de Salud Carlos III-MICINN’ (Spain) and NF-C was supported by a fellowship from the Biomedical Network/nResearch Centre on Rare Diseases (CIBERER)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A role for hypocretin/orexin receptor-1 in cue-induced reinstatement of nicotine-seeking behavior

  • Plaza-Zabala, Ainhoa, 1982-
  • Flores de los Heros, África, 1985-
  • Martín García, Elena, 1975-
  • Saravia Santos, Rocio, 1988-
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
Hypocretin/orexin signaling is critically involved in relapse to drug-seeking behaviors. In this study, we investigated the involvement of the hypocretin system in the reinstatement of nicotine-seeking behavior induced by nicotine-associated cues. Pretreatment with the hypocretin receptor-1 antagonist SB334867, but not with the hypocretin receptor-2 antagonist TCSOX229, attenuated cue-induced reinstatement of nicotine-seeking, which was associated with an activation of hypocretin neurons of the lateral and perifornical hypothalamic areas. In addition, relapse to nicotine-seeking increased the phosphorylation levels of GluR2-Ser880, NR1-Ser890, and p38 MAPK in the nucleus accumbens (NAc), but not in the prefrontal cortex. Notably, phosphorylation levels of NR1-Ser890 and p38 MAPK, but not GluR2-Ser880, were dependent on hypocretin receptor-1 activation. The intra-accumbens infusion of the protein kinase C (PKC) inhibitor NPC-15437 reduced nicotine-seeking behavior elicited by drug-paired cues consistent with the PKC-dependent phosphorylations of GluR2-Ser880 and NR1-Ser890. SB334867 failed to modify cue-induced reinstatement of food-seeking, which did not produce any biochemical changes in the NAc. These data identify hypocretin receptor-1 and PKC signaling as potential targets for the treatment of relapse to nicotine-seeking induced by nicotine-associated cues., This work was supported by the Instituto de Salud Carlos III grants, #PI07/0559, #PI10/00316 and #RD06/001/001 (RTA-RETICS), by the Spanish Ministry of Science and Technology, Consolider-C #SAF2007-64062 and #SAF2011-29864, the Catalan Government (SGR2009-00731), and by the Catalan Institution for Research and Advanced Studies (ICREA Academia program). Ainhoa Plaza-Zabala and África Flores are recipients of a predoctoral fellowship from the Spanish Ministry of Education
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Endocannabinoid system and drug addiction: new insights from mutant mice approaches

  • Maldonado, Rafael, 1961-
  • Robledo, Patricia, 1958-
  • Berrendero Díaz, Fernando, 1971-
The involvement of the endocannabinoid system in drug addiction was initially studied by the use of compounds with different affinities for each cannabinoid receptor or for the proteins involved in endocannabinoids inactivation. The generation of genetically modified mice with selective mutations in these endocannabinoid system components has now provided important advances in establishing their specific contribution to drug addiction. These genetic tools have identified the particular interest of CB1 cannabinoid receptor and endogenous anandamide as potential targets for drug addiction treatment. Novel genetic tools will allow determining if the modulation of CB2 cannabinoid receptor activity and 2-arachidonoylglycerol tone can also have an important therapeutic relevance for drug addiction., This work was supported by the Spanish “Ministerio de Ciencia e Innovación” (#SAF2007-64062 and SAF2011-29864), “Instituto de Salud Carlos III” (RETICS- Red de Trastornos Adictivos-Redes Temáticas de Investigación Cooperativa en Salud: #RD06/0001/0001, #RD06/0001/1004), grants #10/00316 and #10/01708, Plan Nacional sobre Drogas (PNSD #2009/026), the Catalan Government (SGR2009-00131) and the ICREA Foundation (ICREA Academia-2008)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The hypocretin/orexin system: implications for drug reward and relapse

  • Plaza-Zabala, Ainhoa, 1982-
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
Hypocretins (also known as orexins) are hypothalamic neuropeptides involved in the regulation of sleep/wake states and feeding behavior. Recent studies have also demonstrated an important role for the hypocretin/orexin system in the addictive properties of drugs of abuse, consistent with the reciprocal innervations between hypocretin neurons and brain areas involved in reward processing. This system participates in the primary reinforcing effects of opioids, nicotine, and alcohol. Hypocretins are also involved in the neurobiological mechanisms underlying relapse to drug-seeking behavior induced by drug-related environmental stimuli and stress, as mainly described in the case of psychostimulants. Based on these preclinical studies, the use of selective ligands targeting hypocretin receptors could represent a new therapeutical strategy for the treatment of substance abuse disorders. In this review, we discuss and update the current knowledge about the participation of the hypocretin system in drug addiction and the possible neurobiological mechanisms involved in these processes regulated by hypocretin transmission., This work was supported by the Instituto de Salud Carlos III grants #PI07/0559,/n#PI10/00316, and #RD06/001/001 (RTA-RETICS), by the Spanish Ministry of Science/nand Technology (Consolider-C, #SAF2007-64062), the Catalan Government/n(SGR2009-00731), and by the Catalan Institution for Research and Advanced Studies/n(ICREA Academia program). A Plaza-Zabala is a recipient of a predoctoral fellowship/nfrom the Spanish Ministry of Education.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Operant model of frustrated expected reward in mice

  • Burokas, Aurelijus, 1982-
  • Gutiérrez Cuesta, Javier
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
One aspect of the addictive process that has not been thoroughly investigated is the consequence of the frustrated state occurring when the drug is not available. The present study aimed to validate a novel operant model of frustrated expected reward in mice. C57BL/6J mice were trained in operant conditioning maintained by chocolate-flavoured pellets or cocaine. After the completion of high rates of responding on a progressive ratio schedule, the reward was unexpectedly withheld. The consequences of this frustrated behaviour on anxiety, aggressiveness, perseveration, extinction and reinstatement were investigated. Mice exposed to the frustrated event perseverated in the operant responses and showed increased aggressiveness in the resident-intruder test. These animals also showed higher rates of cue-induced reinstatement of drug seeking. The present study provides a reliable operant model in mice to evaluate a frustrated state following reward unavailability. This animal model could be useful to study the behavioural and neurochemical consequences related to the emotional states generated during the omission of a highly expected reward., This work was supported by the DG Research of the European Commission (PHECOMP, no. LHSM-CT-2007—037669 and GENADDICT, no. LSHM-CT-2004—05166), the Spanish ‘Instituto de Salud Carlos III’ (RTA, no. RD06/001/001), the Spanish ‘Ministerio de Ciencia e Innovación’ (no. SAF2007-64062), the Spanish ‘Ministerio de Sanidad, Política Social e Igualdad’ (Plan/nNacional Sobre Drogas, no. 2009/026), the Catalan Government (SGR2009-00131), the ICREA Foundation (ICREA Academia-2008). A.B. was supported by an FI pre-doctoral fellowship of the Catalan Government; J.G.-C. was supported by a ‘Juan de la Cierva’ postdoctoral fellowship from the Spanish ‘Ministerio de Ciencia e Innovación’; and E.M.-G. was supported by a ‘Sara Borrell’ post-doctoral fellowship from the Spanish ‘Instituto de Salud Carlos III’. Partial support from FEDER funds is also acknowledged
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system

  • Berrendero Díaz, Fernando, 1971-
  • Robledo, Patricia, 1958-
  • Trigo i Rodríguez, Josep M.
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
Nicotine is the primary component of tobacco that maintains the smoking habit and develops addiction. The adaptive changes of nicotinic acetylcholine receptors produced by repeated exposure to nicotine play a crucial role in the establishment of dependence. However, other neurochemical systems also participate in the addictive effects of nicotine including glutamate, cannabinoids, GABA and opioids. This review will cover the involvement of these neurotransmitters in nicotine addictive properties, with a special emphasis on the endogenous opioid system. Thus, endogenous enkephalins and beta-endorphins acting on mu-opioid receptors are involved in nicotine-rewarding effects, whereas opioid peptides derived from prodynorphin participate in nicotine aversive responses. An up-regulation of mu-opioid receptors has been reported after chronic nicotine treatment that could counteract the development of nicotine tolerance, whereas the down-regulation induced on kappa-opioid receptors seems to facilitate nicotine tolerance. Endogenous enkephalins acting on mu-opioid receptors also play a role in the development of physical dependence to nicotine. In agreement with these actions of the endogenous opioid system, the opioid antagonist naltrexone has shown to be effective for smoking cessation in certain sub-populations of smokers., This work was supported by the Spanish “Ministerio de Ciencia e Innovación” (#SAF2007-64062) and “Instituto de Salud Carlos III” (#RD06/001/001, PI070709 and PI070559), the Catalan Government (SGR2009-00131), the ICREA Foundation (ICREA Academia-2008), NIDA (1R01-DA01 6768-0111) and the DG Research of the European Commission (NEWMOOD LSHM-CT-2004-503474; GENADDICT, #LSHM-CT-2004-05166; and PHECOMP, #LSHM-CT-2007-037669). J.M.T and E.M.G. are post-doctoral fellows of Instituto de Salud Carlos III “Contratos posdoctorales de perfeccionamiento Sara Borrell”.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Selective re-expression of β2 nicotinic acetylcholine receptor subunits in the ventral tegmental area of the mouse restores intravenous nicotine self-administration

  • Orejarena Serrano, María-Juliana, 1980-
  • Herrera Solís, Andrea
  • Pons, Stéphanie
  • Maskos, Uwe
  • Maldonado, Rafael, 1961-
  • Robledo, Patricia, 1958-
Beta-2 (β2) nicotinic acetylcholine receptor subunits have been particularly related with nicotine reinforcement. However, the importance of these subunits in the chronic aspects of nicotine addiction has not been established. In this study we evaluated the role of ventral tegmental area (VTA) β2 receptor subunits in the acquisition and maintenance of nicotine self-administration. We used an operant mouse model of intravenous self-administration of different doses of nicotine (15, 30, and 60 μg/kg/infusion) during 10 days in constitutive knockout mice lacking β2 receptor subunits (β2KO), wild-type (WT) controls, mice with β2 receptor subunits re-expressed in the VTA using a lentiviral vector (β2-VEC), and control knockout mice with a sham injection (KO-GFP). The results showed that β2KO mice did not reliably acquire nicotine self-administration at any of the doses tested, while WT controls showed dose-dependent acquisition of this behaviour. β2-VEC mice readily acquired and maintained nicotine self-administration at the effective dose of 15 μg/kg/infusion, while sham KO-GFP mice did not. The recovery of the WT phenotype by the re-expression of β2 receptor subunits within the VTA supports the role of this specific population in nicotine reinforcement, and reveals that they are sufficient for the acquisition and maintenance of systemic nicotine self-administration., This work was supported by the Spanish “Instituto de Salud Carlos III” (RD06/001/001 and PI10/01708), FEDER funds, and Ministerio de Ciencia e Innovación (SAF2007-64062), the Catalan Government (SGR2009-00131), an FP7 ERANET programme (NICO-GENE), the ICREA Foundation (ICREA Academia-2008), and a post-doctoral fellowship from CONACyT to AHS
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Involvement of 5-HT2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour

  • Orejarena Serrano, María-Juliana, 1980-
  • Lanfumey, Laurence
  • Maldonado, Rafael, 1961-
  • Robledo, Patricia, 1958-
The serotonergic system appears crucial for (±)-3,4-methylenedioxymethamphetamine (MDMA) reinforcing properties. Current evidence indicates that serotonin 5-HT2A receptors (5-HT2ARs) modulate mesolimbic dopamine (DA) activity and several behavioural responses related to the addictive properties of psychostimulants. This study evaluated the role of 5-HT2ARs in MDMA-induced reinforcement and hyperlocomotion, and the reinstatement of MDMA-seeking behaviour. Basal and MDMA-stimulated extracellular levels of DA in the nucleus accumbens (NAc) and serotonin and noradrenaline in the prefrontal cortex were also assessed. Self-administration of MDMA was blunted in 5-HT2AR knockout (KO) mice compared to wild-type (WT) littermates at both doses tested (0.125 and 0.25 mg/kg per infusion). Horizontal locomotion was increased by MDMA (10 and 20 mg/kg i.p.) to a higher extent in KO than in WT mice. DA outflow in the NAc was lower in KO compared to WT mice under basal conditions and after MDMA (20 mg/kg) challenge. In WT mice, MDMA (5 and 10 mg/kg i.p.) priming did not reinstate MDMA-seeking behaviour, while cue-induced reinstatement was prominent. This cue-induced reinstatement was blocked by administration of the selective 5-HT2AR antagonist, SR46349B (eplivanserin) at a dose of 0.5 mg/kg, but not at 0.25 mg/kg. Our results indicate that 5-HT2ARs are crucial for MDMA-induced reinforcement and cue-induced reinstatement of MDMA-seeking behaviour. These effects are probably due to the modulation of mesolimbic dopaminergic activity., This work was supported by the Instituto de Salud Carlos III FIS grant no. PI070709 (to P.R.) and Red de trastornos adictivos (RTA-RETICS) grant no. RD06/001/001 (to R.M.), the Ministerio de Ciencia e Innovación grant no. SAF2007-64062 (to R.M.), the Generalitat de Catalunya grant no. 2009SGR00731 and ICREA Academia award (to R.M.) and the European Commission projects GENADDICT (no. LSHM-CT-2004-05166) and PHECOMP (no. LSHM-CT-037669) (both to R.M.)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate

  • La Porta, Carmen, 1985-
  • Bura, S. Andreea, 1978-
  • Aracil Fernández, Auxiliadora
  • Manzanares, Jorge
  • Maldonado, Rafael, 1961-
Joint pain is a common clinical problem for which both inflammatory and degenerative joint diseases are major causes. The purpose of this study was to investigate the role of CB1 and CB2 cannabinoid receptors in the behavioral, histological, and neurochemical alterations associated with joint pain. The murine model of monosodium iodoacetate (MIA) was used to induce joint pain in knockout mice for CB1 (CB1KO) and CB2 cannabinoid receptors (CB2KO) and transgenic mice overexpressing CB2 receptors (CB2xP). In addition, we evaluated the changes induced by MIA in gene expression of CB1 and CB2 cannabinoid receptors and μ-, δ- and κ-opioid receptors in the lumbar spinal cord of these mice. Wild-type mice, as well as CB1KO, CB2KO, and CB2xP mice, developed mechanical allodynia in the ipsilateral paw after MIA intra-articular injection. CB1KO and CB2KO demonstrated similar levels of mechanical allodynia of that observed in wild-type mice in the ipsilateral paw, whereas allodynia was significantly attenuated in CB2xP. Interestingly, CB2KO displayed a contralateral mirror image of pain developing mechanical allodynia also in the contralateral paw. All mouse lines developed similar histological changes after MIA intra-articular injection. Nevertheless, MIA intra-articular injection produced specific changes in the expression of cannabinoid and opioid receptor genes in lumbar spinal cord sections that were further modulated by the genetic alteration of the cannabinoid receptor system. These results revealed that CB2 receptor plays a predominant role in the control of joint pain manifestations and is involved in the adaptive changes induced in the opioid system under this pain state., This work was supported by the Spanish “Ministerio de Ciencia e Innovación” (#SAF2007-64062), “Instituto de Salud Carlos III” (RETICS- Red de Trastornos Adictivos-Redes Temáticas de Investigación Cooperativa en Salud: #RD06/0001/0001, #RD06/0001/1004), Plan Nacional sobre Drogas (PNSD #2009/026), the Catalan Government (SGR2009-00131), the ICREA Foundation (ICREA Academia-2008), the DG Research of the European Commission (GENADDICT, # LSHM-CT-2004-05166, and PHECOMP, # LSHM-CT-2007-037669), CENIT program (CEN-20061005) from/nthe “Centro para el Desarollo Technológico Industrial” from the Spanish Ministry of Science and Innovation. Carmen La Porta (C.L.P) is a recipient of a predoctoral fellowship from the Spanish Ministry of Education. Auxiliadora Aracil-Fernández (A.A.F., predoctoral fellow) and Analía Rico (A.R., technician) are supported by RETICS. The partial support of FEDER funds (EU) is also acknowledged
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Nicotine anxiogenic and rewarding effects are decreased in mice lacking β-endorphin

  • Trigo i Rodríguez, Josep M.
  • Zimmer, Andreas
  • Maldonado, Rafael, 1961-
The endogenous opioid system plays an important role in the behavioral effects of nicotine. Thus, micro-opioid receptor and the endogenous opioids derived from proenkephalin are involved in the central effects of nicotine. However, the role played by the different endogenous opioid peptides in the acute and chronic effects of nicotine remains to be fully established. Mice lacking beta-endorphin were acutely injected with nicotine at different doses to evaluate locomotor, anxiogenic and antinociceptive responses. The rewarding properties of nicotine were evaluated by using the conditioned place-preference paradigm. Mice chronically treated with nicotine were acutely injected with mecamylamine to study the behavioral expression of nicotine withdrawal. Mice lacking beta-endorphin exhibited a spontaneous hypoalgesia and hyperlocomotion and a reduction on the anxiogenic and rewarding effects induced by nicotine. Nicotine induced similar antinociception and hypolocomotion in both genotypes and no differences were found in the development of physical dependence. The dissociation between nicotine rewarding properties and physical dependence suggests a differential implication of beta-endorphin in these addictive related responses., This work was supported by NIDA (1R01-DA01 6768-0111), Ministerio de Ciencia y Tecnología (SAF2007-64062), Instituto de Salud Carlos III Red de Trastornos Adictivos, Generalitat de Catalunya (2005SGR00131 and ICREA Academia). European Commission (GENADDICT OJ 2004/C164, N005166 and PHECOMP LSHM-CT-2007-037669).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Operant self-administration of a sigma ligand improves nociceptive and emotional manifestations of neuropathic pain

  • Bura, S. Andreea, 1978-
  • Guegan, Thomas, 1983-
  • Zamamillo Castanedo, Daniel
  • Vela Hernández, José Miguel
  • Maldonado, Rafael, 1961-
BACKGROUND: The treatment of neuropathic pain is unsatisfactory at the present moment and the sigma 1 receptor has been identified as a new potential target for neuropathic pain. The aim of this study was to use an operant self-administration model to reveal the potential interest of a new sigma 1 receptor antagonist, S1RA, in chronic pain that was developed in mice by a partial ligation of the sciatic nerve. METHODS: Once that chronic pain had reached a steady state, mice were trained to maintain an operant behaviour to self-administer S1RA. The possible abuse liability of the analgesic compound was determined by evaluating operant self-administration in sham-operated mice. The influence of S1RA on the anhedonic state related to chronic pain was also evaluated by measuring the preference for palatable drink (2% sucrose solution) using a recently validated and highly sensitive behavioural device. RESULTS: Nerve-injured mice, but not sham-operated animals, acquired the operant responding to obtain S1RA (6 mg/kg/infusion). After 10 days of S1RA self-administration, neuropathic pain was significantly reduced in nerve-injured mice. In addition, an anhedonic state was revealed in nerve-injured mice by a decreased consumption of palatable drink, which was significantly attenuated by S1RA (25 mg/kg). CONCLUSIONS: These results reveal the analgesic efficacy of the sigma antagonist, S1RA, in neuropathic pain associated with an improvement of the emotional negative state and that was devoided of reinforcing effects. The operant responses evaluated in this new mouse model can have a high predictive value to estimate the clinical benefit/risk ratio of new analgesic compounds to treat chronic pain, such as S1RA., S1RA was provided by Esteve as a gift within research projects funded by the CENIT program (CEN-20061005) from the Centro para el Desarollo Technológico Industrial from the Spanish Ministry of Science and Innovation (#SAF2007-64062), “Redes temáticas de investigación cooperativa en salud (RETICS) del Instituto de Salud Carlos III (RD06/001/001). Red de trastornos adictivos (RTA)”, the Catalan Government (SGR2009-00131), the ICREA Foundation (ICREA Academia-2008) and the DG Research of the European Commission (PHECOMP, #LSHM-CT-2007-037669)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Influence of δ-opioid receptors in the behavioral effects of nicotine

  • Berrendero Díaz, Fernando, 1971-
  • Plaza-Zabala, Ainhoa, 1982-
  • Galeote González, Lola
  • Flores de los Heros, África, 1985-
  • Bura, S. Andreea, 1978-
  • Kieffer, Brigitte L.
  • Maldonado, Rafael, 1961-
Multiple studies in animal models and humans suggest that the endogenous opioid system is an important neurobiological substrate for nicotine addictive properties. In this study, we evaluated the participation of δ-opioid receptors in different behavioral responses of nicotine by using δ-opioid receptor knockout mice. Acute nicotine administration induced hypolocomotion and antinociception in wild-type mice, which were similar in knockout animals. The development of tolerance to nicotine-induced antinociception was also similar in both genotypes. In agreement, the expression and functional activity of δ-opioid receptors were not modified in the different layers of the spinal cord and brain areas evaluated after chronic nicotine treatment. The somatic manifestation of the nicotine withdrawal syndrome precipitated by mecamylamine was also similar in wild-type and δ-opioid receptor knockout mice. In contrast, nicotine induced a conditioned place preference in wild-type animals that was abolished in knockout mice. Moreover, a lower percentage of acquisition of intravenous nicotine self-administration was observed in mice lacking δ-opioid receptors as well as in wild-type mice treated with the selective δ-opioid receptor antagonist naltrindole. Accordingly, in-vivo microdialysis studies revealed that the enhancement in dopamine extracellular levels induced by nicotine in the nucleus accumbens was reduced in mutant mice. In summary, the present results show that δ-opioid receptors are involved in the modulation of nicotine rewarding effects. However, this opioid receptor does not participate either in several acute effects of nicotine or in the development of tolerance and physical dependence induced by chronic nicotine administration., This work was supported by the Spanish “Ministerio de Ciencia e Innovación”/n(#SAF2007-64062 and #SAF-2011-29864), the “Instituto de Salud Carlos III” grants/n#PI07/0559, #PI10/00316 and #RD06/001/001, the “Plan Nacional Sobre Drogas”/n(#2009/026), the Catalan Government (SGR2009-00131), and the ICREA Foundation/n(ICREA Academia Award-2008) to R.M. Partial support of FEDER funds is also acknowledged.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Operant behavior to obtain palatable food modifies neuronal plasticity in the brain reward circuit

  • Guegan, Thomas, 1983-
  • Cutando Ruiz, Laura, 1985-
  • Ayuso, Eduard
  • Santini, Emanuela
  • Fisone, Gilberto
  • Bosch, Fatima
  • Martínez, Albert
  • Valjent, Emmanuel
  • Maldonado, Rafael, 1961-
  • Martín Sánchez, Miquel, 1971-
Palatability enhances food intake by hedonic mechanisms that prevail over caloric necessities. Different studies have demonstrated the role of endogenous cannabinoids in the mesocorticolimbic system in controlling food hedonic value and consumption. We hypothesize that the endogenous cannabinoid system could also be involved in the development of food-induced behavioral alterations, such as food-seeking and binge-eating, by a mechanism that requires neuroplastic changes in the brain reward pathway. For this purpose, we evaluated the role of the CB1 cannabinoid receptor (CB1-R) in the behavioral and neuroplastic changes induced by operant training for standard, highly caloric or highly palatable isocaloric food using different genetics, viral and pharmacological approaches. Neuroplasticity was evaluated by measuring changes in dendritic spine density in neurons previously labeled with the dye DiI. Only operant training to obtain highly palatable isocaloric food induced neuroplastic changes in neurons of the nucleus accumbens shell and prefrontal cortex that were associated to changes in food-seeking behavior. These behavioral and neuroplastic modifications induced by highly palatable isocaloric food were dependent on the activity of the CB1-R. Neuroplastic changes induced by highly palatable isocaloric food are similar to those produced by some drugs of abuse and may be crucial in the alteration of food-seeking behavior leading to overweight and obesity., This work was supported by the Spanish Ministerio de Ciencia e Innovació (#SAF2007-64062 and #SAF2008-00962), the Instituto de Salud CarlosIII (#RD06/001/001), the Plan Nacional sobre Drogas, the Catalan Government (SGR2009-00131 and SGR2009-224), the ICREA Foundation (ICREA Academia-2008), the DG Research of the European Commission (GENADDICT,/n#LSHM-CT-2004-05166; and PHECOMP, #LSHM-CT-2007-037669) the FIS’’ (PI07/0715),ATIP-Avenir and Sanofi-Aventis grants.This work was also supported by the Plan Nacional Sobre Drogas (#2009/026) to R.M.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Overexpression of α3/α5/β4 nicotinic receptor subunits modifies impulsive-like behavior

  • Viñals Álvarez, Xavier, 1985-
  • Molas Casacuberta, Susanna, 1985-
  • Gallego, Xavier
  • Fernández Montes, Rubén D.
  • Robledo, Patricia, 1958-
  • Dierssen, Mara
  • Maldonado, Rafael, 1961-
Recent studies have revealed that sequence variants in genes encoding the α3/α5/β4 nicotinic acetylcholine receptor subunits are associated with nicotine dependence. In this study, we evaluated two specific aspects of executive functioning related to drug addiction (impulsivity and working memory) in transgenic mice over expressing α3/α5/β4 nicotinic receptor subunits. Impulsivity and working memory were evaluated in an operant delayed alternation task, where mice must inhibit responding between 2 and 8s in order to receive food reinforcement. Working memory was also evaluated in a spontaneous alternation task in an open field. Transgenic mice showed less impulsive-like behavior than wild-type controls, and this behavioral phenotype was related to the number of copies of the transgene. Thus, transgenic Line 22 (16-28 copies) showed a more pronounced phenotype than Line 30 (4-5 copies). Overexpression of these subunits in Line 22 reduced spontaneous alternation behavior suggesting deficits in working memory processing in this particular paradigm. These results reveal the involvement of α3/α5/β4 nicotinic receptor subunits in working memory and impulsivity, two behavioral traits directly related to the vulnerability to develop nicotine dependence., Funding for this study was provided by the DG Research of the European Commission (PHECOMP, no. LHSM-CT-2007-037669), the Spanish ‘Instituto de Salud Carlos III’ (RD06/001/001; PI082038/nand PI10/01708, EU/FIS PS09102673, ERARare), the Spanish ‘Ministerio de Educación y Ciencia’ (SAF2007-64062; SAF2007-60827; SAF2007-31093-E; SAF2010-16427), Fundación Ramón Areces, Reina Sofia, Marató TV3, and CIBERER, The Catalan Government (SGR2009-00131; 2009SGR-1313) and the ICREA Foundation (ICREA Academia-2008)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The hypocretin/orexin receptor-1 as a novel target to modulate cannabinoid reward

  • Flores de los Heros, África, 1985-
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
BACKGROUND: Cannabis is the most widely used illicit drug in the world. Although there is a high prevalence of users who seek treatment for cannabis dependence, no accepted pharmacologic treatment is available to facilitate and maintain abstinence. The hypocretin/orexin system plays a critical role in drug addiction, but the potential participation of this system in the addictive properties of cannabinoids is unknown. METHODS: We investigated the effects of hypocretins in the intravenous self-administration of the synthetic cannabinoid agonist WIN55,212-2 using hypocretin receptor-1 (Hcrtr-1) and hypocretin receptor-2 antagonists and Hcrtr-1 knockout mice. Additional groups of mice were trained to obtain water to rule out operant responding impairments. Activation of hypocretin neurons was analyzed by using double-label immunofluorescence of FosB/ΔFosB with hypocretin-1. Microdialysis studies were performed to evaluate dopamine extracellular levels in the nucleus accumbens after acute Δ(9)-tetrahydrocannabinol administration.RESULTS: Systemic administration of the Hcrtr-1 antagonist SB334867 reduced intravenous self-administration of WIN55,212-2, as well as the maximum effort to obtain a WIN55,212-2 infusion, as revealed under a progressive ratio schedule. This role of Hcrtr-1 in the reinforcing and motivational properties of WIN55,212-2 was confirmed in Hcrtr-1 knockout mice. Contingent, but not noncontingent, WIN55,212-2 self-administration increased the percentage of hypocretin cells expressing FosB/ΔFosB in the lateral hypothalamus. The enhancement in dopamine extracellular levels in the nucleus accumbens induced by Δ(9)-tetrahydrocannabinol was blocked in mice lacking the Hcrtr-1. CONCLUSIONS: /nThese findings demonstrate that Hcrtr-1 modulates the reinforcing properties of cannabinoids, which could have a clear therapeutic interest., This work was supported by the Instituto de Salud Carlos III grants, #PI07/0559, #PI10/00316 and #RD06/001/001 (RTA-RETICS), by the Spanish Ministry of Science and Technology, Consolider-C #SAF2007-64062 and #SAF2011-29864, the Catalan Government (SGR2009-00731), and by the Catalan Institution for Research and Advanced Studies (ICREA Academia program). África Flores is recipient of a predoctoral fellowship from the Spanish Ministry of Education
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain

  • Racz, Ildiko
  • Nadal i Roura, Xavier, 1980-
  • Alferink, Judith
  • Baños i Díez, Josep Eladi
  • Rehnelt, Jennifer
  • Martín Sánchez, Miquel, 1971-
  • Pintado, Belén
  • Gutierrez-Adan, Alfonso
  • Sanguino, Elena
  • Manzanares, Jorge
  • Zimmer, Andreas
  • Maldonado, Rafael, 1961-
Neuropathic pain is a clinical manifestation of nerve injury difficult to treat even with potent analgesic compounds. Here, we used different lines of genetically modified mice to clarify the role played by CB2 cannabinoid receptors in the regulation of the central immune responses leading to the development of neuropathic pain. CB2 knock-out mice and wild-type littermates were exposed to sciatic nerve injury, and both genotypes developed a similar hyperalgesia and allodynia in the ipsilateral paw. Most strikingly, knock-outs also developed a contralateral mirror image pain, associated with an enhanced microglial and astrocytic expression in the contralateral spinal horn. In agreement, hyperalgesia, allodynia, and microglial and astrocytic activation induced by sciatic nerve injury were attenuated in transgenic mice overexpressing CB2 receptors. These results demonstrate the crucial role of CB2 cannabinoid receptor in modulating glial activation in response to nerve injury. The enhanced manifestations of neuropathic pain were replicated in irradiated wild-type mice reconstituted with bone marrow cells from CB2 knock-outs, thus demonstrating the implication of the CB2 receptor expressed in hematopoietic cells in the development of neuropathic pain at the spinal cord., This work was supported by grants from the National Institute on Drug Abuse (1R01-DA016768-0111) (R.M.,A.Z.), European Commission [Framework VI, GENADDICT OJ 2004/C164, 005166 (R.M., A.Z.); PHECOM, LSHM-CT-2007-037669 (R.M.)], Ministerio de Educación y Ciencia (BFU2004-00920/BFI; SAF2007-64062) (R.M.), Generalitat de Catalunya (R.M.), Deutsche Forschungsgemeinschaft (SFB645; FOR926) (A.Z.), and Bundesministerium für Bildung und Forschung (NGFN2) (A.Z.).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior

  • Plaza-Zabala, Ainhoa, 1982-
  • Martín García, Elena, 1975-
  • Lecea, Luis de
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
Emerging evidence suggests that the hypocretinergic system is involved in addictive behavior. In this study, we investigated the role of these hypothalamic neuropeptides in anxiety-like responses of nicotine and stress-induced reinstatement of nicotine-seeking behavior. Acute nicotine (0.8 mg/kg, s.c.) induced anxiogenic-like effects in the elevated plus-maze and activated the paraventricular nucleus of the/nhypothalamus (PVN) as revealed by c-Fos expression. Pretreatment with the hypocretin receptor 1 (Hcrtr-1) antagonist SB334867 or/npreprohypocretin gene deletion blocked both nicotine effects. In the PVN, SB334867 also prevented the activation of corticotrophin/nreleasing factor (CRF) and arginine-vasopressin (AVP) neurons, which expressed Hcrtr-1. In addition, an increase of the percentage of c-Fos-positive hypocretin cells in the perifornical and dorsomedial hypothalamic (PFA/DMH) areas was found after nicotine (0.8 mg/kg,/ns.c.) administration. Intracerebroventricular infusion of hypocretin-1 (Hcrt-1) (0.75 nmol/1 l) or footshock stress reinstated a previously/nextinguished nicotine-seeking behavior. The effects of Hcrt-1 were blocked by SB334867, but not by the CRF1 receptor antagonist/nantalarmin. Moreover, SB334867 did not block CRF-dependent footshock-induced reinstatement of nicotine-seeking while antalarmin was effective in preventing this nicotine motivational response. Therefore, the Hcrt system interacts with CRF and AVP neurons in the PVN and modulates the anxiogenic-like effects of nicotine whereas Hcrt and CRF play a different role in the reinstatement of nicotineseeking./nIndeed, Hcrt-1 reinstates nicotine-seeking through a mechanism independent of CRF activation whereas CRF mediates the reinstatement induced by stress., This work was supported by the Instituto de Salud Carlos III Grants PI070559 (FIS) and RD06/001/001 (RTA-RETICS), by the Spanish Ministry of Science and Technology (Consolider-C, SAF2007-64062), by the European Commission (IP LSHM-CT-2004-05166, GENADDICT; and STREP LHSM-CT-2007-037669, PHECOMP), by the Catalan Institution for Research and Advanced Studies (ICREA Academia program), and by Generalitat de Catalunya (2009SGR00731). L.d.L. is supported by grants from the National Institute on Drug Abuse, National Alliance for Research on Schizophrenia and Depression, and Defense Advanced Research Projects Agency.E.M.-G.was supported by a postdoctoral fellowship from the Spanish Instituto de Salud Carlos III. A.P.-Z. is a recipient of a predoctoral fellowship from the Spanish Ministry of Education. We thank R. Cabrera, M. Linares, T. Hansson, and C. Fernández-Avilés for invaluable technical assistance, and T. Sakurai and M. Yanagisawa for generously providing preprohypocretin knock-out mice
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far

  • Flores de los Heros, África, 1985-
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
Emerging findings suggest the existence of a cross-talk between hypocretinergic and endocannabinoid systems. Although few studies have examined this relationship, the apparent overlap observed in the neuroanatomical distribution of both systems as well as their putative functions strongly point to the existence of such cross-modulation. In agreement, biochemical and functional studies have revealed the existence of heterodimers between CB1 cannabinoid receptor and hypocretin receptor-1, which modulates the cellular localization and downstream signaling of both receptors. Moreover, the activation of hypocretin receptor-1 stimulates the synthesis of 2-arachidonoyl glycerol culminating in the retrograde inhibition of neighboring cells and suggesting that endocannabinoids could contribute to some hypocretin effects. Pharmacological data indicate that endocannabinoids and hypocretins might have common physiological functions in the regulation of appetite, reward and analgesia. In contrast, these neuromodulatory systems seem to play antagonistic roles in the regulation of sleep/wake cycle and anxiety-like responses. The present review attempts to piece together what is known about this interesting interaction and describes its potential therapeutic implications., This work was supported by the Instituto de Salud CarlosIII grants, #PI07/0559, #PI10/00316 and #RD06/001/001 (RTA-RETICS), by the Spanish Ministry of Science and Technology, Consolider-C #SAF2007-64062 and #SAF2011-29864, the Catalan Government (SGR2009-00731), and by the Catalan Institution for Research and Advanced Studies (ICREA Academia program). África Flores is recipient of a predoctoral fellowship from the Spanish Ministry of Education
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Hypocretin/orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawal

  • Plaza-Zabala, Ainhoa, 1982-
  • Flores de los Heros, África, 1985-
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
BACKGROUND: Hypocretin (orexin) signaling is involved in drug addiction. In this study, we investigated the role of these hypothalamic neuropeptides in nicotine withdrawal by using behavioral and neuroanatomical approaches. METHODS: Nicotine withdrawal syndrome was precipitated by mecamylamine (2 mg/kg, subcutaneous) in C57BL/6J nicotine-dependent mice (25 mg/kg/day for 14 days) pretreated with the hypocretin receptor 1 (Hcrtr-1) antagonist SB334867 (5 and 10 mg/kg, intraperitoneal), the hypocretin receptor 2 antagonist TCSOX229 (5 and 10 mg/kg, intraperitoneal), and in preprohypocretin knockout mice. c-Fos expression was analyzed in several brain areas related to nicotine dependence by immunofluorescence techniques. Retrograde tracing with rhodamine-labeled fluorescent latex microspheres was used to determine whether the hypocretin neurons project directly to the paraventricular nucleus of the hypothalamus (PVN), and SB334867 was locally administered intra-PVN (10 nmol/side) to test the specific involvement of Hcrtr-1 in this brain area during nicotine withdrawal./nRESULTS: Somatic signs of nicotine withdrawal were attenuated in mice pretreated with SB334867 and in preprohypocretin knockout mice. No changes were found in TCSOX229 pretreated animals. Nicotine withdrawal increased the percentage of hypocretin cells expressing c-Fos in the perifornical, dorsomedial, and lateral hypothalamus. In addition, the increased c-Fos expression in the PVN during withdrawal was dependent on hypocretin transmission through Hcrtr-1 activation. Hypocretin neurons directly innervate the PVN and the local infusion of SB334867 into the PVN decreased the expression of nicotine withdrawal. CONCLUSIONS: These data demonstrate that hypocretin signaling acting on Hcrtr-1 in the PVN plays a crucial role in the expression of nicotine withdrawal., This work was supported by the Instituto de Salud Carlos III grants #PI07/0559,/n#PI10/00316, and #RD06/001/001 (RTA-RETICS), by the Spanish Ministry of Science/nand Technology (Consolider-C, #SAF2007-64062), the Catalan Government/n(SGR2009-00731), and by the Catalan Institution for Research and Advanced Studies/n(ICREA Academia program). A Plaza-Zabala is a recipient of a predoctoral fellowship/nfrom the Spanish Ministry of Education